Banvit Bandirma Vitaminli Yem Sanayii Anonim Sirketi (BANVT) Fair Value & Analysis

Consumer Defensive · TR · Market cap 15.5B TRY

Below-average quality, and screening another 36% overvalued on our models.

What matters now

• The price sits above even our optimistic bull case (123.65 TRY). The favourable scenario is already priced in.
• Weak quality (28/100) and above fair value at the same time, the margin of safety is missing on both counts.
• The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
• A fairly wide model range (61.35 TRY to 123.65 TRY) leaves room in how you read the outcome.

Price vs Fair Value (5 years)

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 5, 2026.

How to read this chart

60‑month range 54.95 TRY – 437.50 TRY · fair‑value band 61.35 TRY – 123.65 TRY · the 154.60 TRY price screens above the 98.45 TRY fair value. Dashed = 300-day average. As of Aug 5, 2026.

Which stocks are undervalued right now? Check free Discover now →

Analysis

Banvit Bandirma Vitaminli Yem Sanayii Anonim Sirketi (BANVT) currently trades at 154.60 TRY, while our model-based Fair Value estimate is 98.45 TRY, implying the stock looks roughly 36.3% overvalued today. We read business quality at 28/100 (below-average quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).

Over the trailing twelve months, Banvit Bandirma Vitaminli Yem Sanayii Anonim Sirketi generated revenue of 31.3B TRY at a net margin of -12.4%. Revenue declined 21.4% year over year. It earns a return on equity of -34.8%. Net debt stands at 209M TRY. Fundamentals as of Aug 5, 2026

Our scenario range runs from 61.35 TRY (bear case) to 123.65 TRY (bull case); at 154.60 TRY, the current price sits above that range. The share trades about 31% below its 52-week high and 7% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -3% fair-value upside, at -36%, BANVT screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Widest divergence: Asset-Based (1,911 TRY) versus Dividend Discount (82.99 TRY). Highest evidence: Gordon GGM (70).

Key figures & financial health

Quality Score breakdown

About the company

Banvit Bandirma Vitaminli Yem Sanayii Anonim Sirketi operates as a food company in Turkey. It engages in production, processing, sales, and marketing of feed, breeder eggs, day-old broiler chicks, live broilers, broiler meat, and further processed products. The company also exports its products. It distributes its products through the branches and dealers.

Full company description

Banvit Bandirma Vitaminli Yem Sanayii Anonim Sirketi operates as a food company in Turkey. It engages in production, processing, sales, and marketing of feed, breeder eggs, day-old broiler chicks, live broilers, broiler meat, and further processed products. The company also exports its products. It distributes its products through the branches and dealers. The company was incorporated in 1968 and is headquartered in Balikesir, Turkey. Banvit Bandirma Vitaminli Yem Sanayii Anonim Sirketi is a subsidiary of BRF GmbH.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Banvit Bandirma Vitaminli Yem Sanayii Anonim Sirketi reported revenue of 33.5B TRY in FY2025 versus 5.3B TRY in FY2021, a compound +58.4%/yr. Reported net income was −3.1B TRY in FY2025.

BANVT screens 36% overvalued. Compare with Nestlé India Limited →

Peer Group

Packaged Foods · 672 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Valuation Multiples vs Packaged Foods median · lower = cheaper

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Aug 5, 2026).

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

Frequently asked questions

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.